Related Experiment Video
Updated: Feb 10, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
Chronic Hepatitis C and Direct Acting Antivirals
Maria Westerhoff1, Joseph Ahn2
1University of Michigan, 1301 Catherine Street, 5231 Medical Science Building 1, Ann Arbor, MI 48104, USA.
Insights
Hepatitis C virus (HCV) infection is a leading cause of liver disease. Recent direct-acting antiviral therapies have dramatically improved cure rates for HCV, offering new hope for patients.
Area of Science:
- Hepatology
- Virology
- Pathology
Background:
- Hepatitis C virus (HCV) is a major U.S. blood-borne pathogen.
- HCV is the primary cause of end-stage liver disease and liver transplant necessity.
- HCV treatment has seen significant advancements in the past decade.
Purpose of the Study:
- To provide pathologists and clinicians with an overview of HCV.
- To detail the histologic findings associated with HCV infection.
- To discuss the impact and application of direct-acting antiviral therapies for HCV.
Main Methods:
- Review of current literature on HCV pathology.
- Analysis of histologic features in HCV-infected patients.
- Examination of direct-acting antiviral treatment outcomes.
Main Results:
- Direct-acting antiviral therapies have increased HCV cure rates to over 90%.
- Histologic findings provide crucial diagnostic and prognostic information.
- Successful treatment significantly impacts liver disease progression.
Conclusions:
- Direct-acting antivirals represent a revolutionary advancement in HCV management.
- Understanding HCV histology is essential for accurate diagnosis and monitoring.
- Improved treatment outcomes underscore the importance of accessible care.
Abstract:
The hepatitis C virus (HCV) is the most common blood-borne infection in the United States and is the most common cause of end-stage liver disease requiring liver transplant. Over the last 10 years, direct acting antiviral therapies have revolutionized HCV treatment, increasing the cure rates from less than 50% to more than 90% in those who reach access to care. This article is an overview for pathologists and clinicians covering the histologic findings of HCV as well as direct acting antiviral therapy.
More Related Videos
Related Concept Videos
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Forces Acting on Chromosomes
Microtubules and motor proteins exert two types of forces on...

